Literature DB >> 19451346

Soluble guanylate cyclase: not a dull enzyme.

Guido Boerrigter, John C Burnett.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19451346     DOI: 10.1161/CIRCULATIONAHA.109.860288

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  Role of guanylate cyclase modulators in decompensated heart failure.

Authors:  Veselin Mitrovic; Adrian F Hernandez; Markus Meyer; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

Review 2.  Novel vasodilators in heart failure.

Authors:  Payman Zamani; Barry H Greenberg
Journal:  Curr Heart Fail Rep       Date:  2013-03

Review 3.  The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.

Authors:  Isabelle Six; Nicolas Guillaume; Valentine Jacob; Romuald Mentaverri; Said Kamel; Agnès Boullier; Michel Slama
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

4.  Riociguat: first global approval.

Authors:  Daniel Conole; Lesley J Scott
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

5.  Role of nitric oxide signaling in endothelial differentiation of embryonic stem cells.

Authors:  Ngan F Huang; Felix Fleissner; John Sun; John P Cooke
Journal:  Stem Cells Dev       Date:  2010-10       Impact factor: 3.272

Review 6.  Mechanisms and Models in Heart Failure: A Translational Approach.

Authors:  Douglas L Mann; G Michael Felker
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

Review 7.  Uremic Toxins and Vascular Dysfunction.

Authors:  Isabelle Six; Nadia Flissi; Gaëlle Lenglet; Loïc Louvet; Said Kamel; Marlène Gallet; Ziad A Massy; Sophie Liabeuf
Journal:  Toxins (Basel)       Date:  2020-06-18       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.